Two-Drug, Single-Tablet Idvynso Receives FDA Approval for HIV-1

Summary: The FDA just approved a new HIV medicine called Idvynso. It is a single tablet taken once a day that combines two different drugs. It is made for adults whose HIV is already well-controlled but who want or need to switch from their current daily treatment.

In clinical studies, Idvynso worked just as well as older treatments at keeping the virus suppressed. It gives patients a new choice that doesn't contain the drug tenofovir. Some common side effects include diarrhea, dizziness, and headache.

For more details, see rssapp-empr-com at empr.com/news/two-drug-single-tablet-idvynso-receives-fda-approval-for-hiv-1/ (opens in new tab)